Evidence map›Paper›PMID 27595345›Full record

ArticleNature microbiology2016

Intra-host dynamics of Ebola virus during 2014.

Ming Ni, Chen Chen, Jun Qian, Hai-Xia Xiao, Wei-Feng Shi, Yang Luo, Hai-Yin Wang, Zhen Li, Jun Wu, Pei-Song Xu and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genomic Epidemiology ofPathogens (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Ming NiBeijing Institute of Radiation Medicine, Beijing 100850, China.
Chen ChenInstitute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
Jun QianKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122, China.
Hai-Xia XiaoCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Wei-Feng ShiInstitute of Pathogen Biology, Taishan Medical College, Taian 271016, China.
Yang LuoWellcome Trust Sanger Institute, Cambridge CB10 1SA, UK.
Hai-Yin WangInstitute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
Zhen LiBeijing Institute of Radiation Medicine, Beijing 100850, China.
Jun WuCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Pei-Song XuZhiyuan Medical Inspection Institute, Zhejiang 310009, China.
Su-Hong ChenBeijing Institute of Radiation Medicine, Beijing 100850, China.
Gary WongCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Yuhai BiCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Zhi-Ping XiaKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122, China.
Wei LiNetwork Information Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Hui-Jun LuKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122, China.
Juncai MaNetwork Information Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Yi-Gang TongState Key Laboratory of Pathogen and Biosecurity, Beijing 100071, China.
Hui ZengInstitute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
Sheng-Qi WangBeijing Institute of Radiation Medicine, Beijing 100850, China.
George F GaoCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Xiao-Chen BoBeijing Institute of Radiation Medicine, Beijing 100850, China.
Di LiuCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.ORCID http://orcid.org/0000-0003-3693-2726
Chinese Academy of Sciences · CNBeijing Radiation Center · CNJilin University · CNBeijing Ditan Hospital · CNCapital Medical University · CNChinese Center For Disease Control and Prevention · CNShanghai Special Equipment Supervision and Inspection Institute · CNTaishan Medical University · CNWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2013, West Africa has encountered the largest Ebola virus (EBOV) disease outbreak on record, and Sierra Leone is the worst-affected country, with nearly half of the infections. By means of next-generation sequencing and phylogeographic analysis, the epidemiology and transmission of EBOV have been well elucidated. However, the intra-host dynamics that mainly reflect viral-host interactions still need to be studied. Here, we show a total of 710 intra-host single nucleotide variations (iSNVs) from deep-sequenced samples from EBOV-infected patients, through a well-tailored bioinformatics pipeline. We present a comprehensive distribution of iSNVs during this outbreak and along the EBOV genome. Analyses of iSNV and its allele frequency reveal that VP40 is the most conserved gene during this outbreak, and thus it would be an ideal therapeutic target. In the co-occurring iSNV network, varied iSNV sites present different selection features. Intriguingly, the T-to-C substitutions at the 3'-UTR of the nucleoprotein (NP; positions 3008 and 3011), observed in many patients, result in the upregulation of the transcription of NP through an Ebola mini-genome reporting system. Additionally, no iSNV enrichment within B-cell epitopes of GP has been observed.

Indexed as

Genetic VariationHost-Pathogen InteractionsPolymorphism, Single NucleotideAllelesEbolavirusEpitopes, B-LymphocyteGenome, ViralHemorrhagic Fever, EbolaHigh-Throughput Nucleotide SequencingHumansNucleoproteinsQuasispeciesViral Matrix ProteinsEpitopes, B-LymphocyteNucleoproteinsViral Matrix ProteinsVP40 protein, virus

Identifiers

PMID27595345
OpenAlexW2518343196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.